Comparative proteomics analysis of differential proteins in respond to doxorubicin resistance in myelogenous leukemia cell lines

BACKGROUND: Chemoresistance remains a significant challenge in chronic myelogenous leukemia (CML) management, which is one of the most critical prognostic factors. Elucidation the molecular mechanisms underlying the resistance to chemoresistance may lead to better clinical outcomes. RESULTS: In orde...

Descripción completa

Detalles Bibliográficos
Autores principales: Qinghong, Shi, Shen, Gao, Lina, Song, Yueming, Zhao, Xiaoou, Li, Jianlin, Wu, Chengyan, He, Hongjun, Li, Haifeng, Zhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307195/
https://www.ncbi.nlm.nih.gov/pubmed/25628518
http://dx.doi.org/10.1186/s12953-014-0057-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307195/
https://www.ncbi.nlm.nih.gov/pubmed/25628518
http://dx.doi.org/10.1186/s12953-014-0057-y

Ejemplares similares